IP Library › Granted Patent US 12,410,467
Granted Patent B2
US 12,410,467 · App. 17/625,500 · Granted Sep 9, 2025

Bisulfite-free, whole genome methylation analysis

Inventors: Chunxiao Song (Oxford, GB); Jingfei Cheng (Oxford, GB); Paulina Siejka-Zielinska (Oxford, GB); Yibin Liu (Oxford, GB)
Assignee: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
C12Q1/683C12Q1/6806C12Q1/6869C12Q2600/154
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,410,467
App. No.
17/625,500
Granted
Sep 9, 2025
Kind
B2
Abstract

This disclosure provides methods for cost-effective bisulfite-free identification in DNA, including whole genomic DNA, of the locations of one or more of 5-methylcytosine, 5-hydroxymethylcytosine, 5-carboxylcytosine and 5-formylcytosine. The methods described herein are based on the conversion of modified cytosine (5mC, 5hmC, 5fC, 5caC) to dihydrouracil (DHU), for example by TET-assisted pyridine borane treatment, followed by endonuclease cleavage of the DHU, and identification of the cleavage site, which corresponds to the location of the modified cytosine.

Claims (12)

1. A method for cleaving a modified target DNA, the method comprising:

converting 5-carboxylcytosine (5caC) and/or 5-formylcytosine (5fC) in a target DNA to dihydrouracil (DHU) with a borane reducing agent to provide a modified target DNA comprising one or more DHU; and

contacting the modified target DNA comprising one or more DHU with one or more DHU-sensitive endonucleases that cleave the modified target DNA at, or adjacent to, the one or more DHU.

2. The method of claim 1 , wherein the borane reducing agent is selected from the group consisting of pyridine borane, 2-picoline borane (pic-BH3), borane, sodium borohydride, sodium cyanoborohydride, and sodium triacetoxyborohydride.

3. The method of claim 1 , wherein the one or more DHU-sensitive endonucleases are selected from one or more of the group consisting of a mixture of a combination of Uracil DNA glycosylase (UDG) and DNA glycosylase-lyase Endonuclease VIII, Endonuclease III, Tma Endonuclease III, Endonuclease VIII, and Formamidopyrimidine DNA Glycosylase (Fpg).

4. The method of claim 1 , wherein the one or more DHU-sensitive endonucleases comprise a mixture of a combination of UDG and Endonuclease VIII.

5. The method of claim 1 , further comprising the step of adding adapter DNA molecules to the cleaved modified target DNA.

6. The method of claim 1 , further comprising detecting the sequence of the cleaved modified target DNA, wherein the presence of a cleavage site provides the location of either a 5caC or 5fC in the target DNA.

7. The method of claim 1 , wherein:

the borane reducing agent is selected from the group consisting of pyridine borane, 2-picoline borane (pic-BH3), borane, sodium borohydride, sodium cyanoborohydride, and sodium triacetoxyborohydride; and

the one or more DHU-sensitive endonucleases are selected from one or more of the group consisting of a mixture of a combination of Uracil DNA glycosylase (UDG) and DNA glycosylase-lyase Endonuclease VIII, Endonuclease III, Tma Endonuclease III, Endonuclease VIII, and Formamidopyrimidine DNA Glycosylase (Fpg).

8. The method of claim 7 , wherein the one or more DHU-sensitive endonucleases comprise a mixture of a combination of UDG and Endonuclease VIII.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2022
From: CHENG, JINGFEI; SONG, CHUNXIAO; LIU, YIBIN; SIEJKA-ZIELINSKA, PAULINA
To: THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Reel/Frame 061209/0839 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2022
From: THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
To: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Reel/Frame 061209/0882 →
Continuity (2)
Provisional Application 62871444 · Jul 8, 2019
Related Publication 20220275424A1 · Sep 1, 2022
References Cited (109)
US 7582420B2 · Oliphant et al. · 2009 [cited by applicant]
US 8741567B2 · He et al. · 2014 [cited by applicant]
US 9267117B2 · Guan et al. · 2016 [cited by applicant]
US 20130157261A1 · Sharpe · 2013 [cited by examiner]
US 20140127678A1 · Guan et al. · 2014 [cited by applicant]
US 20140322707A1 · He et al. · 2014 [cited by applicant]
US 20170176421A1 · Rao et al. · 2017 [cited by applicant]
US 20170253924A1 · Lu et al. · 2017 [cited by applicant]
US 20180251815A1 · Okamoto et al. · 2018 [cited by applicant]
US 20200024643A1 · Arensdorf et al. · 2020 [cited by applicant]
US 20200370114A1 · Song et al. · 2020 [cited by applicant]
CN 111971386A · 2020 [cited by applicant]
CN 115181783A · 2022 [cited by applicant]
EP 2694686 · 2017 [cited by applicant]
WO WO2008091541A1 · 2008 [cited by applicant]
WO WO2013017853 · 2013 [cited by applicant]
WO WO2014074450 · 2014 [cited by applicant]
WO WO2014083118 · 2014 [cited by applicant]
WO WO2014165770 · 2014 [cited by applicant]
WO WO2015021282 · 2015 [cited by applicant]
WO WO2016164363 · 2016 [cited by applicant]
WO WO2017039002 · 2017 [cited by applicant]
WO WO2017176630 · 2017 [cited by applicant]
WO WO2017192633A1 · 2017 [cited by examiner]
WO WO2019136413 · 2019 [cited by applicant]
WO WO2024076981A2 · 2024 [cited by applicant]
Cheng et al. Nucleic Acids Research. 2021. 49(13):e76 and Supplemental. (Year: 2021). [cited by examiner]
Liu et al. Nature Chem. Biol. 2017. 13:181-187. (Year: 2017). [cited by examiner]
Ambrogelly et al., Screening of reducing agents for the PEGylation of recombinant human IL-10. Protein J. Jun. 2013;32(5):337-42. [cited by applicant]
Amemiya et al., The ENCODE Blacklist: Identification of Problematic Regions of the Genome. Sci Rep. Jun. 27, 2019;9(1):9354. 5 pages. [cited by applicant]
Aparici-Espert et al., A Combined Experimental and Theoretical Approach to the Photogeneration of 5,6-Dihydropyrimidin-5-yl Radicals in Nonaqueous Media. J Org Chem. May 20, 2016;81(10):4031-8. [cited by applicant]
Bachman et al., 5-Formylcytosine can be a stable DNA modification in mammals. Nat Chem Biol. Aug. 2015;11(8):555-7. [cited by applicant]
Bogu et al., Chromatin and RNA Maps Reveal Regulatory Long Noncoding RNAs in Mouse. Mol Cell Biol. Dec. 28, 2015;36(5):809-19. [cited by applicant]
Booth et al., Chemical methods for decoding cytosine modifications in DNA. Chem Rev. Mar. 25, 2015;115(6):2240-54. [cited by applicant]
Booth et al., Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science. May 18, 2012;336(6083):934-7. [cited by applicant]
Chaurasia et al., Application of crude laccase of Xylaria polymorpha MTCC-1100 in selective oxidation of aromatic methyl group to aldehyde group. BCAIJ, 2012. 6(7), 237-242. [cited by applicant]
Darst et al., Bisulfite sequencing of DNA. Curr Protoc Mol Biol. Jul. 2010;Chapter 7:Unit 7.9.1-17. [cited by applicant]
Dietzsch et al., Chemoselective labeling and site-specific mapping of 5-formylcytosine as a cellular nucleic acid modification. FEBS Lett. Jun. 2018;592(12):2032-2047. [cited by applicant]
Dizdaroglu et al., Substrate specificity of the [cited by applicant]
ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. Sep. 6, 2012;489(7414):57-74. [cited by applicant]
Ernst et al., ChromHMM: autmating chromatin-state discovery and characterization. Nat Methods. Feb. 28, 2012;9(3):215-6. [cited by applicant]
Extended European Search Report for PCT/US2019012627. Mailed Sep. 21, 2020. 9 pages. [cited by applicant]
GenBank—EMBL Accession No. J02459. Jan. 2020. 33 pages. [cited by applicant]
He et al., DeepH&M: Estimating single-CpG hydroxymethylation and methylation levels from enrichment and restriction enzyme sequencing methods. Sci Adv. Jul. 1, 2020;6(27):eaba0521. 11 pages. [cited by applicant]
He et al., Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. Sep. 2, 2011;333(6047):1303-7. [cited by applicant]
Holmes et al., Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine. PLOS One. Apr. 3, 2014;9(4):e93933. 15 pages. [cited by applicant]
House et al., Hydrolysis of dihydrouridine and related compounds. Biochemistry. Jan. 9, 1996;35(1):315-20. [cited by applicant]
Incarnato et al., High-throughput single nucleotide variant discovery in E14 mouse embryonic stem cells provides a new reference genome assembly. Genomics. Aug. 2014;104(2):121-7. [cited by applicant]
International Search Report for PCT/US2019/012627, Mailed May 7, 2019. 5 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/IB2020/056435. Mailed Oct. 19, 2020. 10 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/IB2021/000630. Mailed Jan. 31, 2022. 21 pages. [cited by applicant]
International Search Report and Written Opinion, PCT/US2019/017902. Dated Apr. 11, 2019, 6 pages. [cited by applicant]
Ito et al., Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. Sep. 2, 2011;333(6047):1300-3. [cited by applicant]
Iyer et al., Comparative genomics of transcription factors and chromatin proteins in parasitic protists and other eukaryotes. Int J Parasitol. Jan. 2008;38(1):1-31. [cited by applicant]
Jiang et al., Characterization of [cited by applicant]
Kellinger et al., 5-formylcytosine and 5-carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription. Nat Struct Mol Biol. Aug. 2012;19(8):831-3. [cited by applicant]
Kent et al., BigWig and BigBed: enabling browsing of large distributed datasets. Bioinformatics. Sep. 1, 2010;26(17):2204-7. [cited by applicant]
Kim et al., CTCF as a multifunctional protein in genome regulation and gene expression. Exp Mol Med. Jun. 5, 2015;47(6):e166. 5 pages. [cited by applicant]
Kriaucionis et al. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. May 15, 2009;324(5929):929-30. [cited by applicant]
Krueger et al., Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. Jun. 1, 2011;27(11):1571-2. [cited by applicant]
Kundaje et al., mod/mouse/humanENCODE: Blacklisted genomic regions for functional genomics analysis. Stanford School of Medicine. 2014. 3 pages. [cited by applicant]
Langmead et al., Fast gapped-read alignment with Bowtie 2. Nat Methods. Mar. 4, 2012;9(4):357-9. [cited by applicant]
Li et al., DNA methylation in mammals. Cold Spring Harb Perspect Biol. May 1, 2014;6(5):a019133. 21 pages. [cited by applicant]
Li et al., Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. Jul. 15, 2009;25(14):1754-60. [cited by applicant]
Li et al., The Sequence Alignment/Map format and SAMtools. Bioinformatics. Aug. 15, 2009;25(16):2078-9. [cited by applicant]
Liu et al., Accurate targeted long-read DNA methylation and hydroxymethylation sequencing with TAPS. Genome Biol. Mar. 3, 2020;21(1):54. 9 pages. [cited by applicant]
Liu et al., Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution. Nat Biotechnol. Apr. 2019;37(4):424-429. [cited by applicant]
Liu et al., Bisulfite-free, Base-resolution, and Quantitative Sequencing of CytosineModifications. bioRxiv, 2018. pp. 1-18. [cited by applicant]
Liu et al., DNA 5-Methylcytosine-Specific Amplification and Sequencing. J Am Chem Soc. Mar. 11, 2020;142(10):4539-4543. [cited by applicant]
Lu et al., Chemical modification-assisted bisulfite sequencing (CAB-Seq) for 5-carboxylcytosine detection in Dna. J Am Chem Soc. Jun. 26, 2013;135(25):9315-7. [cited by applicant]
Matsushita et al., DNA-friendly Cu(ii)/TEMPO-catalyzed 5-hydroxymethylcytosine-specific oxidation. Chem Commun (Camb). May 23, 2017;53(42):5756-5759. [cited by applicant]
Meissner et al., Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. Oct. 13, 2005;33(18):5868-77. [cited by applicant]
Mellen et al., MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. Dec. 21, 2012;151(7):1417-30. [cited by applicant]
Moriya et al., A novel modified nucleoside found at the first position of the anticodon of methionine tRNA from bovine liver mitochondria. Biochemistry. Mar. 1, 1994;33(8):2234-9. [cited by applicant]
Neri et al., Intragenic DNA methylation prevents spurious transcription initiation. Nature. Mar. 2, 2017;543(7643):72-77. [cited by applicant]
Nestor et al., Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. Mar. 2012;22(3):467-77. [cited by applicant]
Pais et al., Biochemical characterization of a Naegleria TET-like oxygenase and its application in single molecule sequencing of 5-methylcytosine. Proc Natl Acad Sci U S A. Apr. 7, 2015;112(14):4316- 21. [cited by applicant]
Plongthongkum et al., Advances in the profiling of DNA modifications: cytosine methylation and beyond. Nat Rev Genet. Oct. 2014;15(10):647-61. [cited by applicant]
Ponnaluri et al., A mechanistic overview of TET-mediated 5-methylcytosine oxidation. Biochem Biophys Res Commun. Jun. 28, 2013;436(2):115-20. [cited by applicant]
Qu et al., MLML: consistent simultaneous estimates of DNA methylation and hydroxymethylation. Bioinformatics. Oct. 15, 2013;29(20):2645-6. [cited by applicant]
Quinlan et al., BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. Mar. 15, 2010;26(6):841-2. [cited by applicant]
Roberston et al., A novel method for the efficient and selective identification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. Apr. 2011;39(8):e55. pp. 1-10. [cited by applicant]
Robinson et al., Integrative genomics viewer. Nat Biotechnol. Jan. 2011;29(1):24-6. [cited by applicant]
Rosenbloom et al., ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. Jan. 2013;41(Database issue):D56-63. [cited by applicant]
Ruhaak et al., 2-picoline-borane: a non-toxic reducing agent for oligosaccharide labeling by reductive amination. Proteomics. Jun. 2010;10(12):2330-6. [cited by applicant]
Schuler et al., Sequencing the sixth base (5-hydroxymethylcytosine): selective DNA oxidation enables base-pair resolution. Angew Chem Int Ed Engl. Oct. 22, 2012;51(43):10704-7. [cited by applicant]
Schutsky et al., Nondestructive, base-resolution sequencing of 5-hydroxymethylcytosine using a DNA deaminase. Nat Biotechnol. Oct. 8, 2018;10.1038/nbt.4204. 23 pages. [cited by applicant]
Shen et al., A map of the cis-regulatory sequences in the mouse genome. Nature. Aug. 2, 2012;488(7409):116-20. [cited by applicant]
Song et al., 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell Res. Oct. 2017;27(10):1-12. [cited by applicant]
Song et al., Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell. Apr. 25, 2013;153(3):678-91. [cited by applicant]
Song et al., Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol. Jan. 2011;29(1):68-72. [cited by applicant]
Song. Bisulfite-free, base resolution and quantitative identification of cytosine modifications. Keystone Symposia Conference, DNA & RNA Methylation, Ludwig Institute for Cancer Research, University of Oxford, Jan. 24, … [cited by applicant]
Tahiliani et al., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. May 15, 2009;324(5929):930-5. [cited by applicant]
Tanaka et al., Degradation of DNA by bisulfite treatment. Bioorg Med Chem Lett. Apr. 1, 2007;17(7):1912-5. [cited by applicant]
Therasse et. al., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institu… [cited by applicant]
Vaisvila et al., Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA. Genome Res. Jun. 17, 2021;31(7):1280-1289. [cited by applicant]
Wang et al., Bisulfite-free, single base-resolution analysis of 5-hydroxymethylcytosine in genomic DNA by chemical-mediated mismatch. Chem Sci. Oct. 11, 2018;10(2):447-452. [cited by applicant]
Wen et al., Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain. Genome Biol. Mar. 4, 2014;15(3):R49. 17 pages. [cited by applicant]
Written Opinion, PCT/US2019/012627. mailed May 7, 2019. 12 pages. [cited by applicant]
Wu et al., Base-resolution profiling of active DNA demethylation using MAB-seq and caMAB-seq. Nat Protoc. Jun. 2016;11(6):1081-100. [cited by applicant]
Xia et al., Bisulfite-free, base-resolution analysis of 5-formylcytosine at the genome scale. Nat Methods. Nov. 2015;12(11):1047-50. [cited by applicant]
Yu et al., Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell. Jun. 8, 2012;149(6):1368-80. [cited by applicant]
Yu et al., Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine. Nat Protoc. Dec. 2012;7(12):2159-70. [cited by applicant]
Zeng et al., Bisulfite-Free, Nanoscale Analysis of 5-Hydroxymethylcytosine at Single Base Resolution. J Am Chem Soc. Oct. 17, 2018;140(41):13190-13194. [cited by applicant]
Zhao et al., Mapping the epigenetic modifications of DNA and RNA. Protein Cell. Nov. 2020;11(11):792-808. [cited by applicant]
Zhu et al., Single-Cell 5-Formylcytosine Landscapes of Mammalian Early Embryos and ESCs at Single-Base Resolution. Cell Stem Cell. May 4, 2017;20(5):720-731.e5. [cited by applicant]
Extended European Search Report for European Application No. 23203846.3, mailed Feb. 26, 2024, 10 Pages. [cited by applicant]
Guo Y., et al., “The Oxidative Dna Glycosylases of [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/IB2020/056435, mailed Jan. 20, 2022, 8 Pages. [cited by applicant]